Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis

Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis

(2017) Xin Pan et al.   BMJ Open

Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study

(2015) Eiji Oki et al.   International Journal of Clinical Oncology

Preventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in rats

(2015) Toru Kono et al.   Scientific Reports

The Kampo Medicine Goshajinkigan Prevents Neuropathy in Breast Cancer Patients Treated with Docetaxel

(2014) Hajime Abe et al.   Asian Pacific Journal of Cancer Prevention

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

(2014) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

Goshajinkigan, a Traditional Japanese Medicine, Prevents Oxaliplatin-Induced Acute Peripheral Neuropathy by Suppressing Functional Alteration of TRP Channels in Rat

(2014) Keita Mizuno et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

The Prophylactic Effects of a Traditional Japanese Medicine, Goshajinkigan, on Paclitaxel-Induced Peripheral Neuropathy and its Mechanism of Action

(2014) Yukiko Matsumura et al.   Molecular Pain

Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis

(2014) Marta Seretny et al.   PAIN

Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review

(2014) Floortje Mols et al.   SUPPORTIVE CARE IN CANCER

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2013) Alessandro Liberati   ANNALS OF INTERNAL MEDICINE

P2-043 * REDUCTION OF PACLITAXEL-RELATED PERIPHERAL SENSORY NEUROPATHY BY GOSHA-JINKI-GAN OR CARBON DIOXIDE FEET AND HAND BATHING

(2013) K. Kawabata et al.   ANNALS OF ONCOLOGY

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy

(2013) Toru Kono et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Herbal Medicine Goshajinkigan Prevents Paclitaxel-Induced Mechanical Allodynia without Impairing Antitumor Activity of Paclitaxel

(2013) Muh. Akbar Bahar et al.   Evidence-based Complementary and Alternative Medicine

Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients

(2013) Naohisa Yoshida et al.   Journal of Oncology

Empirical Evaluation of Very Large Treatment Effects of Medical Interventions

(2012) Tiago V. Pereira et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Furosemide versus Gosha-Jinki-Gan, a Blended Herbal Medicine, for Nocturnal Polyuria: A Randomized Crossover Trial

(2012) Koji YOSHIMURA et al.   LUTS-Lower Urinary Tract Symptoms

Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents

(2011) Soichiro Ushio et al.   EUROPEAN JOURNAL OF CANCER

Discrepancy between the NCI-CTCAE and DEB-NTC scales in the evaluation of oxaliplatin-related neurotoxicity in patients with metastatic colorectal cancer

(2011) Naohiko Inoue et al.   International Journal of Clinical Oncology

The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen

(2011) Masanori Nishioka et al.   International Journal of Clinical Oncology

Objective evaluation of the alleviating effects of Goshajinkigan on peripheral neuropathy induced by paclitaxel/carboplatin therapy: A multicenter collaborative study

(2011) HIROI KAKU et al.   Experimental and Therapeutic Medicine